Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ensysce Biosciences Inc.

    NASDAQ: ENSC · Real-Time Price · USD
    2.10
    -0.05 (-2.33%)
    At close: Jun 17, 2025, 3:59 PM
    2.08
    -0.95%
    After-hours: Jun 17, 2025, 05:28 PM EDT

    Ensysce Biosciences Statistics

    Share Statistics

    Ensysce Biosciences has 2.37M shares outstanding. The number of shares has increased by 176.49% in one year.

    Shares Outstanding

    n/a
    		 2.37M

    Shares Change (YoY)

    n/a
    		 176.49%

    Shares Change (QoQ)

    n/a
    		 7.68%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 2.33M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,789

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 98K, so 4.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 98K

    Short % of Shares Out

    n/a
    		 4.13%

    Short % of Float

    n/a
    		 4.18%

    Short Ratio (days to cover)

    n/a
    		 1.06

    Valuation Ratios

    The PE ratio is -1.78 and the forward PE ratio is -41.04. Ensysce Biosciences's PEG ratio is 0.71.

    PE Ratio

    n/a
    		 -1.78

    Forward PE

    n/a
    		 -41.04

    PS Ratio

    n/a
    		 2.73

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0.71
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ensysce Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 2.42

    Quick Ratio

    n/a
    		 2.42

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -5.22

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $744,285.71

    Profits Per Employee

    n/a
    		 $-1,141,000

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0.93

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -72.82% in the last 52 weeks. The beta is 0.98, so Ensysce Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.98

    52-Week Price Change

    n/a
    		 -72.82%

    50-Day Moving Average

    n/a
    		 2.3

    200-Day Moving Average

    n/a
    		 5.15

    Relative Strength Index (RSI)

    n/a
    		 45.14

    Average Volume (20 Days)

    n/a
    		 1,742,061

    Income Statement

    In the last 12 months, Ensysce Biosciences had revenue of 5.21M and earned -7.99M in profits. Earnings per share was -4.57.

    Revenue

    n/a
    		 5.21M

    Gross Profit

    n/a
    		 5.21M

    Operating Income

    n/a
    		 -6.73M

    Net Income

    n/a
    		 -7.99M

    EBITDA

    n/a
    		 -6.73M

    EBIT

    n/a
    		 -6.73M

    Earnings Per Share (EPS)

    n/a
    		 -4.57
    Full Income Statement

    Balance Sheet

    The company has 3.5M in cash and 301.66K in debt, giving a net cash position of 3.2M.

    Cash & Cash Equivalents

    n/a
    		 3.5M

    Total Debt

    n/a
    		 301.66K

    Net Cash

    n/a
    		 3.2M

    Retained Earnings

    n/a
    		 -129,544.3B

    Total Assets

    n/a
    		 4.61M

    Working Capital

    n/a
    		 2.64M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7,502.7B and capital expenditures 0, giving a free cash flow of -7,502.7B.

    Operating Cash Flow

    n/a
    		 -7,502.7B

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -7,502.7B

    FCF Per Share

    n/a
    		 -4295637.32
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -129.18% and -153.3%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -129.18%

    Pretax Margin

    n/a
    		 -153.3%

    Profit Margin

    n/a
    		 -153.3%

    EBITDA Margin

    n/a
    		 -129.18%

    EBIT Margin

    n/a
    		 -129.17%

    FCF Margin

    n/a
    		 -144005758.16%

    Dividends & Yields

    ENSC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ENSC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 6, 2024. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Dec 6, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -17.45

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist